Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

Table 1

Plasma Gas6, sAxl, and sMerTK concentrations at different time points (t0, t7, and t14). Values are expressed as median (IQR).

Laboratory findings (ng/ml)	Median (IQR)
Gas6
t0	46.8 (38.2-59.6)
t7	36.6 (27.7-45.9)
t14	36.1 (28.1-41.7)
sAxl
t0	16.7 (10.7-27.4)
t7	26.2 (14.9-39.6)
t14	22.5 (15.7-29.8)
sMerTK
t0	33.7 (25.3-38.4)
t7	28.0 (21.4-34.8)
t14	24.3 (21.2-30.3)